Anatomic Pathology Market Size (2024 - 2029)

The anatomic pathology market is anticipated to experience stable growth over the forecast period, driven by factors such as the increasing prevalence of cancer, a growing focus on personalized medicine, and advancements in pathology equipment. Despite the initial impact of the COVID-19 pandemic on diagnostic services, the market has shown resilience as cancer diagnosis procedures have resumed normalcy. The development of global communities and initiatives by organizations to advance digital pathology also contributes to market expansion. However, challenges such as stringent government regulations and a shortage of skilled professionals may impede market growth.

Market Size of Anatomic Pathology Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Anatomic Pathology Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.50 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Anatomic Pathology Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Anatomic Pathology Market Analysis

The anatomical pathology market is expected to register a CAGR of 6.5% during the forecast period.

The COVID-19 outbreak impacted every aspect of the diagnostics industry, including the anatomic pathology market. During the initial pandemic, the number of patient visits to hospitals reduced significantly despite emergency services being available in hospitals. For instance, according to an article published by BMC Health Services Research in February 2022, a study was conducted in the Netherlands, which showed that the initial COVID-19 pandemic significantly impacted diagnostic pathology or anatomic pathology in the country. Thus, the COVID-19 pandemic significantly impacted the market initially. However, as the pandemic has subsided, cancer diagnosis procedures are taking place normally. Hence, the studied market is expected to have stable growth during the forecast period of the study.

Factors that are driving the market growth are the high incidence of cancer and other target diseases, the growing focus on personalized medicine, and the high usage of advanced pathology equipment.

The rising prevalence of cancer is a major factor driving the market growth, as anatomic pathology is used for the diagnosis of these diseases. For instance, according to the data published by the Spanish Network of Cancer Registries in January 2021, an estimated 0.28 million new cases of cancer were expected in Spain in 2021, out of which 43.6 thousand colorectal cancer cases, 35.8 thousand prostate cancer cases, and 33.4 thousand breast cancer cases were expected.

Moreover, according to the data published by the National Cancer Center Japan in June 2022, an estimated 1,019,000 new cases of cancer were expected in Japan in 2022, out of which 158,200 were new cases of colon/rectum cancer, 132,100 cases of stomach cancer, 128,800 cases of lung/trachea cancer, 96,400 cases of prostate cancer, and 95,000 cases of breast cancer. Thus, the greater incidence of cancers has increased the demand for various anatomic pathology products for the diagnosis of cancers.

Additionally, the rising developments by various organizations are also expected to enhance market growth. For instance, in October 2022, pathologists from Europe, Japan, and the United States jointly debuted the Digital Pathology Connections (DPC), a global community for professionals interested in the digital future of the anatomic pathology laboratory.

Thus, the aforementioned factors, such as the rising prevalence of cancer, increasing demand for personalized medicines, and the rising developments by various organizations, are expected to enhance the market growth. However, stringent government regulations pertaining to anatomic pathology and the lack of skilled professionals are expected to hinder market growth.

Anatomic Pathology Industry Segmentation

As per the scope of the report, anatomic pathology is a medical specialty that is concerned with the diagnosis of disease based on the microscopic, macroscopic, biochemical, immunologic, and molecular examination of organs and tissues. Anatomic pathology involves the visualization of human tissue under a microscope for proper diagnosis of a disease or a pathological condition. Microscopic examination of tissue samples with the help of one or more stains is a standard procedure performed in anatomic pathology. The anatomic pathology market is segmented by products & services (instruments, consumables, and services), applications (disease diagnosis, drug discovery and development, and other applications), end users (hospitals, research laboratories, diagnostic laboratories, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD) for the above segments.

By Product & Services
Instruments
Consumables
Services
By Application
Disease Diagnosis
Drug Discovery and Development
Others
By End User
Hospitals
Research Laboratories
Diagnostic Laboratories
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Anatomic Pathology Market Size Summary

The anatomic pathology market is poised for steady growth, driven by the increasing incidence of cancer and the rising focus on personalized medicine. The market experienced initial disruptions due to the COVID-19 pandemic, which led to a significant reduction in patient visits and diagnostic procedures. However, as the pandemic's impact waned, normalcy returned to cancer diagnosis procedures, fostering a stable growth trajectory. The demand for advanced pathology equipment and the development of digital pathology communities further bolster market expansion. Despite challenges such as stringent government regulations and a shortage of skilled professionals, the market is expected to benefit from ongoing advancements and collaborations among key industry players.

The consumables segment is anticipated to maintain a significant market share, supported by the high usage rate and availability of pathology consumables. The rising prevalence of cancer, particularly breast cancer, is expected to drive the consumption of these products, especially in screening procedures. North America stands out as a major revenue-generating region, attributed to the presence of leading market players, supportive government initiatives, and advanced healthcare infrastructure. Strategic initiatives by companies, such as product launches and acquisitions, are expected to enhance market growth. The market remains moderately fragmented, with key players like Thermo Fisher Scientific Inc. and Quest Diagnostics Incorporated actively engaging in product innovation and strategic expansions.

Explore More

Anatomic Pathology Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 High Incidence of Cancer and Other Target Diseases

      2. 1.2.2 Growing Focus on Personalized Medicine

      3. 1.2.3 High Usage of Advanced Pathology Equipment

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Government Regulations Pertaining to Anatomic Pathology

      2. 1.3.2 Lack of Skilled Professionals

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size - Value in USD million)

    1. 2.1 By Product & Services

      1. 2.1.1 Instruments

      2. 2.1.2 Consumables

      3. 2.1.3 Services

    2. 2.2 By Application

      1. 2.2.1 Disease Diagnosis

      2. 2.2.2 Drug Discovery and Development

      3. 2.2.3 Others

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Research Laboratories

      3. 2.3.3 Diagnostic Laboratories

      4. 2.3.4 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Anatomic Pathology Market Size FAQs

The Global Anatomic Pathology Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)

Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings and Agilent Technologies, Inc. are the major companies operating in the Global Anatomic Pathology Market.

Anatomic Pathology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)